JCIC Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-115
Closed -$4K 93
2020
Q1
$4K Sell
115
-85,167
-100% -$3.33M ﹤0.01% 92
2019
Q4
$3.86M Sell
85,282
-2,279
-3% -$95.4K 1.49% 25
2019
Q3
$3.56M Sell
87,561
-1,470
-2% -$62.3K 1.57% 24
2019
Q2
$3.83M Sell
89,031
-965
-1% -$37.1K 1.59% 27
2019
Q1
$3.45M Buy
89,996
+996
+1% +$38K 1.37% 33
2018
Q4
$3.15M Sell
89,000
-135
-0.2% -$4.9K 1.39% 31
2018
Q3
$3.43M Buy
+89,135
New +$3.11M 1.18% 33

Other funds holding BSX

JCIC Asset Management's BSX Position: Q2 2020 in Review

JCIC Asset Management sold out of Boston Scientific (BSX) in Q2 2020, closing a stake of 115 shares — an estimated $4K sold.

JCIC Asset Management first reported a position in BSX in Q3 2018 and held it in 7 quarters. The position peaked at $3.86M in Q4 2019. 840 funds tracked by Wall St. Rank hold BSX as of Q2 2020.

  • JCIC Asset Management reported no remaining Boston Scientific position as of Q2 2020 after selling out during the quarter.
  • JCIC Asset Management sold 115 Boston Scientific shares in Q2 2020, an estimated $4K.
  • JCIC Asset Management first reported a position in Boston Scientific in Q3 2018 and held it in 7 quarters.
  • JCIC Asset Management's Boston Scientific position peaked at $3.86M in Q4 2019.
  • 840 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2020.

Based on JCIC Asset Management's 13F filing for Q2 2020, filed 7 Aug 2020.